Effects of anti-IL 17 on inflammation in Asthma, COPD and Asthma-COPD models
F. Almeida (São Paulo (SP), Brazil), L. Camargo (São Paulo (SP), Brazil), N. Martins (São Paulo (SP), Brazil), J. Lourenço (São Paulo (SP), Brazil), S. Bezerra (São Paulo (SP), Brazil), B. Saraiva-Romanholo (São Paulo (SP), Brazil), E. Leick (São Paulo (SP), Brazil), F. Q.S. Lopes (São Paulo (SP), Brazil), C. Prado (Santos (SP), Brazil), R. Righetti (São Paulo (SP), Brazil), I. Tibério (São Paulo (SP), Brazil)
Source: International Congress 2022 – Clinical and translational studies of asthma and COPD: novel mechanisms
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
F. Almeida (São Paulo (SP), Brazil), L. Camargo (São Paulo (SP), Brazil), N. Martins (São Paulo (SP), Brazil), J. Lourenço (São Paulo (SP), Brazil), S. Bezerra (São Paulo (SP), Brazil), B. Saraiva-Romanholo (São Paulo (SP), Brazil), E. Leick (São Paulo (SP), Brazil), F. Q.S. Lopes (São Paulo (SP), Brazil), C. Prado (Santos (SP), Brazil), R. Righetti (São Paulo (SP), Brazil), I. Tibério (São Paulo (SP), Brazil). Effects of anti-IL 17 on inflammation in Asthma, COPD and Asthma-COPD models. 2255
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
|
|